The Miriam Hospital Ryan White Care Program: drugs

Schedule G of this filing lists 43 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.

The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.

All 43 drug rows

Schedule G as filed, for The Miriam Hospital Ryan White Care Program: 43 drugs, in the order filed
LineDrugAmount as filedClaims as filed
1Eliquis 2.5 mg tab 6000003089321Listed by the FDA as Eliquisapixaban2.5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.6,763.39 (Schedule G, line 1, page 11 of the filing PDF)12
2Eliquis 5 mg tab 6000003089421Listed by the FDA as Eliquisapixaban5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.29,206.51 (Schedule G, line 2, page 11 of the filing PDF)56
3Isentress 400 mg tab 6000006022761Listed by the FDA as Isentressraltegravir400 mgtablet, film coatedMerck Sharp & Dohme LLC17,636.04 (Schedule G, line 3, page 11 of the filing PDF)26
4Pifeltro 100 mg tab 3000006306901Listed by the FDA as Pifeltrodoravirine100 mgtablet, film coatedMerck Sharp & Dohme LLC160,213.45 (Schedule G, line 4, page 11 of the filing PDF)120
5Delstrigo tab 3000006500701Listed by the FDA as Delstrigodoravirine, lamivudine, and tenofovir disoproxil fumarate100 mg; 300 mg; 300 mgtablet, film coatedMerck Sharp & Dohme LLC20,155.11 (Schedule G, line 5, page 11 of the filing PDF)10
6Dupixent SY 300 mg/2 mL 2 pen00024591502Listed by the FDA as Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC17,993.55 (Schedule G, line 6, page 11 of the filing PDF)7
7Mavyret 100/40 mg tab 8400074262528Listed by the FDA as Mavyretglecaprevir and pibrentasvir40 mg; 100 mgtablet, film coatedAbbVie Inc.34,095.60 (Schedule G, line 7, page 11 of the filing PDF)fewer than 6 (the count is not shown)
8Ozempic 1 mg/0.75 mL PFP 3 mL00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP13,720.00 (Schedule G, line 8, page 11 of the filing PDF)32
9Ozempic 0.25/0.5 mg PFP 3 mL00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP16,881.02 (Schedule G, line 9, page 11 of the filing PDF)48
10Wegovy 1.7 mg PFP 4x0.75 mL00169451714Listed by the FDA as Wegovysemaglutide1.7 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP5,424.87 (Schedule G, line 10, page 11 of the filing PDF)10
11Wegovy 2.4 mg PFP 4x0.75 mL00169452414Listed by the FDA as Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP19,162.27 (Schedule G, line 11, page 11 of the filing PDF)34
12Ozempic 2 mg/0.75 mL PFP 3 mL00169477212Listed by the FDA as Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP24,012.61 (Schedule G, line 12, page 11 of the filing PDF)79
13Trelegy Ellipta 200-62.5-25 mcg pwd 6000173089310Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate200 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC14,262.92 (Schedule G, line 13, page 11 of the filing PDF)56
14Cresemba 186 mg cap 14 UD00469052002Listed by the FDA as Cresembaisavuconazonium sulfate100 mgcapsuleAstellas Pharma US, Inc.23,189.48 (Schedule G, line 14, page 11 of the filing PDF)11
15Buprenorphine 20 mcg-hr pat 442858083940Listed by the FDA as Buprenorphine20 mcg/hourpatchRhodes Pharmaceuticals LLC5,248.32 (Schedule G, line 15, page 11 of the filing PDF)67
16Tivicay 50 mg tab 3049702022813Listed by the FDA as Tivicaydolutegravir sodium50 mgtablet, film coatedViiV Healthcare Company438,217.32 (Schedule G, line 16, page 11 of the filing PDF)316
17Triumeq tab 3049702023113Listed by the FDA as Triumeqabacavir sulfate, dolutegravir sodium, lamivudine600 mg; 50 mg; 300 mgtablet, film coatedViiV Healthcare Company602,789.06 (Schedule G, line 17, page 11 of the filing PDF)292
18Cabenuva 600-900 mg sus kit49702024015Listed by the FDA as Cabenuvacabotegravir and rilpivirinekitViiV Healthcare Company3,832,637.65 (Schedule G, line 18, page 11 of the filing PDF)739
19Juluca 50 mg/25 mg tab 3049702024213Listed by the FDA as Julucadolutegravir sodium and rilpivirine hydrochloride50 mg; 25 mgtablet, film coatedViiV Healthcare Company599,268.18 (Schedule G, line 19, page 11 of the filing PDF)239
20Dovato 50 mg-300 mg tab 3049702024613Listed by the FDA as Dovatodolutegravir sodium and lamivudine50 mg; 300 mgtablet, film coatedViiV Healthcare Company2,088,315.21 (Schedule G, line 20, page 11 of the filing PDF)923
21Dovato TB 50-300 mg 30 BPK49702024633Listed by the FDA as Dovatodolutegravir sodium and lamivudine50 mg; 300 mgtablet, film coatedViiV Healthcare Company14,687.65 (Schedule G, line 21, page 12 of the filing PDF)9
22Rukobia 600 mg tab 6049702025018Listed by the FDA as Rukobiafostemsavir tromethamine600 mgtablet, film coated, extended releaseViiV Healthcare Company176,538.43 (Schedule G, line 22, page 12 of the filing PDF)26
23Cabenuva 400-600 mg sus kit49702025315Listed by the FDA as Cabenuvacabotegravir and rilpivirinekitViiV Healthcare Company245,780.78 (Schedule G, line 23, page 12 of the filing PDF)65
24Apretude 600 mg kit49702026423Listed by the FDA as ApretudecabotegravirkitViiV Healthcare Company12,108.66 (Schedule G, line 24, page 12 of the filing PDF)0
25Zubsolv 8.6 mg/2.1 mg tab 3054123098630Listed by the FDA as Zubsolvbuprenorphine hydrochloride and naloxone hydrochloride8.6 mg; 2.1 mgtablet, orally disintegratingOrexo US, Inc.8,583.00 (Schedule G, line 25, page 12 of the filing PDF)12
26Edurant 25 mg tab 3059676027801Listed by the FDA as Edurantrilpivirine hydrochloride25 mgtablet, film coatedJanssen Products, LP22,241.16 (Schedule G, line 26, page 12 of the filing PDF)41
27Prezcobix tab 3059676057530Listed by the FDA as Prezcobixdarunavir ethanolate and cobicistat800 mg; 150 mgtablet, film coatedJanssen Products, LP358,130.44 (Schedule G, line 27, page 12 of the filing PDF)252
28Symtuza tab 3059676080030Listed by the FDA as Symtuzadarunavir, cobicistat, emtricitabine, and tenofovir alafenamide800 mg; 150 mg; 200 mg; 10 mgtablet, film coatedJanssen Products LP542,309.06 (Schedule G, line 28, page 12 of the filing PDF)163
29Complera tab 3061958110101Listed by the FDA as Compleraemtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate200 mg; 25 mg; 300 mgtablet, film coatedGilead Sciences, Inc.37,031.93 (Schedule G, line 29, page 12 of the filing PDF)25
30Stribild tab 3061958120101Listed by the FDA as Stribildelvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate150 mg; 150 mg; 200 mg; 300 mgtablet, film coatedGilead Sciences, Inc.14,378.72 (Schedule G, line 30, page 12 of the filing PDF)8
31Genvoya 150/150/200/10 mg tab 3061958190101Listed by the FDA as Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc.839,588.72 (Schedule G, line 31, page 12 of the filing PDF)327
32Descovy 200-25 mg tab 3061958200201Listed by the FDA as Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc.183,928.41 (Schedule G, line 32, page 12 of the filing PDF)176
33Odefsey 200 mg/25 mg/25 mg tab 3061958210101Listed by the FDA as Odefseyemtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide200 mg; 25 mg; 25 mgtabletGilead Sciences, Inc.561,493.53 (Schedule G, line 33, page 12 of the filing PDF)241
34Vosevi 400/100/100 mg tab 2861958240101Listed by the FDA as Vosevisofosbuvir, velpatasvir, and voxilaprevir400 mg; 100 mg; 100 mgtablet, film coatedGilead Sciences, Inc.49,941.42 (Schedule G, line 34, page 12 of the filing PDF)fewer than 6 (the count is not shown)
35Biktarvy 50 mg/200 mg/25 mg tab 3061958250101Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.13,778,842.94 (Schedule G, line 35, page 12 of the filing PDF)4,695
36Biktarvy TB50-200-25 mg 30CPLT BPK61958250103Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.38,162.76 (Schedule G, line 36, page 12 of the filing PDF)21
37Sunlenca 300 mg tab 461958300101Listed by the FDA as Sunlencalenacapavir sodium300 mgtablet, film coatedGilead Sciences, Inc.14,995.50 (Schedule G, line 37, page 12 of the filing PDF)7
38Sunlenca 300 mg tab 461958300103Listed by the FDA as Sunlencalenacapavir sodium300 mgtablet, film coatedGilead Sciences, Inc.22,462.05 (Schedule G, line 38, page 12 of the filing PDF)8
39Sunlenca 463.5 mg 2x1.5 mL SDV kit61958300201Listed by the FDA as Sunlencalenacapavir sodiumkitGilead Sciences, Inc.147,928.14 (Schedule G, line 39, page 12 of the filing PDF)10
40Sunlenca 463.5 mg 2x1.5 mL SDV kit61958300501Listed by the FDA as Sunlencalenacapavir sodiumkitGilead Sciences, Inc.326,052.88 (Schedule G, line 40, page 12 of the filing PDF)23
41Dapagliflozin 10 mg tab 3066993045730Listed by the FDA as Dapagliflozin10 mgtablet, film coatedPrasco Laboratories5,476.22 (Schedule G, line 41, page 12 of the filing PDF)26
42Sofosbuvir Velpatasvr 400 mg-100 mg tab 2872626270101Listed by the FDA as Sofosbuvir and Velpatasvirvelpatasvir and sofosbuvir100 mg; 400 mgtablet, film coatedAsegua Therapeutics LLC24,047.80 (Schedule G, line 42, page 12 of the filing PDF)fewer than 6 (the count is not shown)
43Syndros 5 mg/mL sol 30 mL78613020130Listed by the FDA as Syndrosdronabinol5 mg/mLsolutionBenuvia Operations, LLC44,915.20 (Schedule G, line 43, page 12 of the filing PDF)fewer than 6 (the count is not shown)
Total Prescription Drugs individually under $5,000122,161.49 (Schedule G, row for amounts under $5,000, page 12 of the filing PDF)12,189 (Schedule G, claims on the row for amounts under $5,000, page 12 of the filing PDF)
Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement25,560,979.45 (Schedule G, printed total, page 12 of the filing PDF)21,414 (Schedule G, printed claims total, page 12 of the filing PDF)

What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.

Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.

Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.

“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. All 43 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched

Source

Filing PDF
Open Schedule G on the State of Rhode Island's website
SHA-256
b2d60b03d26a9948aaf0d1f88623cfefa9503526ffbd07f15214de317b8bf3e1
Retrieved
11 November 2026
Pages used
11 to 12 of 15